AmeriServ Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$216K Buy
+6,331
New +$230K 0.29% 58
2019
Q2
Sell
-11,078
Closed -$446K 74
2019
Q1
$446K Sell
11,078
-2,335
-17% -$93.5K 0.93% 35
2018
Q4
$555K Sell
13,413
-372
-3% -$15.4K 1.41% 27
2018
Q3
$576K Buy
13,785
+1,300
+10% +$50K 0.72% 31
2018
Q2
$430K Buy
12,485
+850
+7% +$29K 0.58% 42
2018
Q1
$392K Sell
11,635
-2,031
-15% -$69.8K 0.44% 45
2017
Q4
$470K Buy
+13,666
New +$466K 0.45% 40
2017
Q1
$444K Sell
13,666
-4,216
-24% -$133K 0.58% 28
2016
Q4
$551K Sell
17,882
-106
-0.6% -$3.24K 0.64% 24
2016
Q3
$578K Sell
17,988
-845
-4% -$28.3K 0.73% 32
2016
Q2
$629K Buy
18,833
+1,054
+6% +$33.6K 0.94% 22
2016
Q1
$500K Buy
17,779
+633
+4% +$18.1K 0.85% 23
2015
Q4
$525K Buy
17,146
+2,108
+14% +$66.3K 1.24% 24
2015
Q3
$448K Buy
15,038
+737
+5% +$23.6K 0.85% 27
2015
Q2
$455K Hold
14,301
0.53% 40
2015
Q1
$472K Sell
14,301
-114
-0.8% -$3.62K 0.54% 43
2014
Q4
$426K Buy
+14,415
New +$413K 0.41% 63
2014
Q1
Sell
-19,838
Closed -$577K 164
2013
Q4
$577K Hold
19,838
0.34% 88
2013
Q3
$541K Hold
19,838
0.34% 88
2013
Q2
$527K Buy
+19,838
New +$548K 0.34% 86

Other funds holding PFE

AmeriServ Wealth Advisors's PFE Position: Q3 2019 in Review

AmeriServ Wealth Advisors opened a new position in Pfizer (PFE) in Q3 2019: 6,331 shares worth $216K. The stake represents 0.29% of the portfolio and ranks #58 among its holdings. This is a return to the name: AmeriServ Wealth Advisors previously reported a position in PFE as recently as Q1 2019.

AmeriServ Wealth Advisors first reported a position in PFE in Q2 2013 and has held it in 20 quarters since. The position peaked at $629K in Q2 2016. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • AmeriServ Wealth Advisors held 6,331 shares of Pfizer worth $216K as of Q3 2019.
  • Pfizer was a new AmeriServ Wealth Advisors position in Q3 2019.
  • Pfizer made up 0.29% of AmeriServ Wealth Advisors's portfolio in Q3 2019, its #58 holding.
  • AmeriServ Wealth Advisors first reported a position in Pfizer in Q2 2013 and has held it in 20 quarters since.
  • AmeriServ Wealth Advisors's Pfizer position peaked at $629K in Q2 2016.
  • 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on AmeriServ Wealth Advisors's 13F filing for Q3 2019, filed 8 Nov 2019.